{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:22:27Z","timestamp":1788218547270,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"DOI":"10.1007\/s00423-023-02893-6","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T13:01:25Z","timestamp":1681995685000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["18F-fluorocholine PET\/MRI versus ultrasound and sestamibi for the localization of parathyroid adenomas"],"prefix":"10.1007","volume":"408","author":[{"given":"ME","family":"Noltes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Rotstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Eskander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WP","family":"Kluijfhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Bongers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. H.","family":"Brouwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kruijff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Metser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JD","family":"Pasternak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Veit-Haibach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"key":"2893_CR1","doi-asserted-by":"crossref","unstructured":"Yeh MW, Ituarte PH, Zhou HC, Nishimoto S, Liu IL, Harari A, Haigh PI, Adams AL  Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab 98(3):1122\u20131129","DOI":"10.1210\/jc.2012-4022"},{"issue":"9684","key":"2893_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","volume":"374","author":"WD Fraser","year":"2009","unstructured":"Fraser WD (2009) Hyperparathyroidism. Lancet 374(9684):145\u2013158","journal-title":"Lancet"},{"issue":"8","key":"2893_CR3","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jama.284.8.934","volume":"284","author":"GL Irvin 3rd","year":"2000","unstructured":"Irvin GL 3rd, Carneiro DM (2000) Management changes in primary hyperparathyroidism. JAMA 284(8):934\u2013936","journal-title":"JAMA"},{"key":"2893_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.otohns.2004.10.005","volume":"132","author":"J Ruda","year":"2005","unstructured":"Ruda J, Hollenbeak C, Stack B (2005) A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 132:359\u2013372","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"5","key":"2893_CR5","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/00000658-200211000-00001","volume":"236","author":"A Bergenfelz","year":"2002","unstructured":"Bergenfelz A, Lindblom P, Tibblin S, Westerdahl J (2002) Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann.Surg 236(5):543\u2013551","journal-title":"Ann.Surg"},{"issue":"8","key":"2893_CR6","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1001\/archsurg.141.8.777","volume":"141","author":"E Kebebew","year":"2006","unstructured":"Kebebew E, Hwang J, Reiff E, Duh QY, Clark OH (2006) Predictors of single-gland vs multigland parathyroid disease in primary hyperparathyroidism: a simple and accurate scoring model. Arch Surg 141(8):777\u2013782; discussion 782","journal-title":"Arch Surg"},{"issue":"2","key":"2893_CR7","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1245\/s10434-011-1870-5","volume":"19","author":"K Cheung","year":"2012","unstructured":"Cheung K, Wang TS, Farrokhyar F, Roman SA, Sosa JA (2012) A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol 19(2):577\u2013583","journal-title":"Ann.Surg.Oncol"},{"issue":"5","key":"2893_CR8","doi-asserted-by":"publisher","first-page":"737","DOI":"10.2967\/jnumed.115.156018","volume":"56","author":"E Hindi\u00e9","year":"2015","unstructured":"Hindi\u00e9 E, Zanotti-Fregonara P, Tabarin A, Rubello D, Morelec I, Wagner T, Henry JF, Ta\u00efeb D (2015) The role of radionuclide imaging in the surgical management of primary hyperparathyroidism. J.Nucl.Med. 56(5):737\u2013744","journal-title":"J.Nucl.Med."},{"issue":"4","key":"2893_CR9","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1007\/s00259-017-3911-1","volume":"45","author":"E Quak","year":"2018","unstructured":"Quak E, Blanchard D, Houdu B, Le Roux Y, Ciappuccini R, Lireux B, de Raucourt D, Grellard JM, Licaj I, Bardet S, Reznik Y, Clarisse B, Aide N (2018) F18-choline PET\/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT\/CT are negative or inconclusive: the APACH1 study. Eur.J.Nucl.Med.Mol.Imaging 45(4):658\u2013666","journal-title":"Eur.J.Nucl.Med.Mol.Imaging"},{"key":"2893_CR10","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s12672-018-0347-4","volume":"9","author":"S Kim","year":"2018","unstructured":"Kim S, Lee S, Jeong S, Pak K, Kim K (2018) Diagnostic performance of F-18 fluorocholine PET\/CT for parathyroid localization in hyperparathyroidism: a systematic review and meta-analysis. Horm Cancer 9:440\u2013447","journal-title":"Horm Cancer"},{"issue":"11","key":"2893_CR11","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1097\/MNM.0000000000000899","volume":"39","author":"M Araz","year":"2018","unstructured":"Araz M, Soydal \u00c7, \u00d6zkan E, Kir MK, \u0130bi\u015f E, G\u00fcll\u00fc S, Erdo\u011fan MF, Emral R, K\u00fc\u00e7\u00fck \u00d6 (2018) The efficacy of fluorine-18-choline PET\/CT in comparison with 99mTc-MIBI SPECT\/CT in the localization of a hyperfunctioning parathyroid gland in primary hyperparathyroidism. Nucl.Med.Commun 39(11):989\u2013994","journal-title":"Nucl.Med.Commun"},{"key":"2893_CR12","doi-asserted-by":"crossref","unstructured":"Broos WAM, Wondergem M, Knol RJJ, van der Zant FM (2019) Parathyroid imaging with (18)F-fluorocholine PET\/CT as a first-line imaging modality in primary hyperparathyroidism: a retrospective cohort study. EJNMMI Res 9(1)","DOI":"10.1186\/s13550-019-0544-3"},{"issue":"10","key":"2893_CR13","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1007\/s00259-018-4018-z","volume":"45","author":"S Grimaldi","year":"2018","unstructured":"Grimaldi S, Young J, Kamenicky P, Hartl D, Terroir M, Leboulleux S, Berdelou A, Hadoux J, Hescot S, Remy H, Baudin E, Schlumberger M, Deandreis D (2018) Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of (18)F-Fluorocholine PET\/CT. Eur.J.Nucl.Med.Mol.Imaging 45(10):1772\u20131780","journal-title":"Eur.J.Nucl.Med.Mol.Imaging"},{"key":"2893_CR14","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3389\/fendo.2017.00380","volume":"8","author":"S Fischli","year":"2018","unstructured":"Fischli S, Suter-Widmer I, Nguyen BT, M\u00fcller W, Metzger J, Strobel K, Gr\u00fcnig H, Henzen C (2018) The significance of 18F-fluorocholine-PET\/CT as localizing imaging technique in patients with primary hyperparathyroidism and negative conventional imaging. Front.Endocrinol 8:380","journal-title":"Front.Endocrinol"},{"issue":"5","key":"2893_CR15","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1007\/s00268-019-04910-6","volume":"43","author":"C Amadou","year":"2019","unstructured":"Amadou C, Bera G, Ezziane M, Chami L, Delbot T, Rouxel A, Leban M, Herve G, Menegaux F, Leenhardt L, Kas A, Tr\u00e9sallet C, Ghander C, Lussey-Lepoutre C (2019) 18F-fluorocholine PET\/CT and parathyroid 4D computed tomography for primary hyperparathyroidism: the challenge of reoperative patients. World J Surg 43(5):1232\u20131242","journal-title":"World J Surg"},{"issue":"9","key":"2893_CR16","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s12149-020-01507-1","volume":"34","author":"L Evangelista","year":"2020","unstructured":"Evangelista L, Ravelli I, Magnani F, Iacobone M, Giraudo C, Camozzi V, Spimpolo A, Cecchin D (2020) (18)F-choline PET\/CT and PET\/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature. Ann.Nucl.Med. 34(9):601\u2013619","journal-title":"Ann.Nucl.Med."},{"issue":"4","key":"2893_CR17","doi-asserted-by":"publisher","first-page":"584","DOI":"10.2967\/jnumed.119.233213","volume":"61","author":"Y Liu","year":"2020","unstructured":"Liu Y, Dang Y, Huo L, Hu Y, Wang O, Liu H, Chang X, Liu Y, Xing X, Li F, Liao Q, Hacker M, Li X, Kreissl M (2020) Preoperative localisation of adenomas in primary hyperparathyroidism: the value of 11C-choline PET\/CT in patients with negative or discordant ultrasonography and 99mTc-Sesta-MIBI-SPECT\/CT. J Nucl Med 61(4):584\u2013589","journal-title":"J Nucl Med"},{"issue":"11","key":"2893_CR18","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3390\/diagnostics10110975","volume":"10","author":"A Ismail","year":"2020","unstructured":"Ismail A, Christensen JW, Krakauer M, S\u00f8ndergaard SB, Zerahn B, Nygaard B, Bennedb\u00e6k FN, Kristensen B, Jensen LT (2020) (11)C-choline PET\/CT vs. (99m)Tc-MIBI\/(123)iodide subtraction SPECT\/CT for preoperative detection of abnormal parathyroid glands in primary hyperparathyroidism: a prospective, single-centre clinical trial in 60 patients. Diagnostics 10(11):975. https:\/\/doi.org\/10.3390\/diagnostics10110975","journal-title":"Diagnostics"},{"issue":"1","key":"2893_CR19","doi-asserted-by":"publisher","first-page":"32-021-00778-7","DOI":"10.1186\/s13550-021-00778-7","volume":"11","author":"ME Noltes","year":"2021","unstructured":"Noltes ME, Kruijff S, Jansen L, Westerlaan HE, Zandee WT, Dierckx RAJO, Brouwers AH (2021) A retrospective analysis of the diagnostic performance of (11)C-choline PET\/CT for detection of hyperfunctioning parathyroid glands after prior negative or discordant imaging in primary hyperparathyroidism. EJNMMI Res 11(1):32-021-00778-7","journal-title":"EJNMMI Res"},{"issue":"2","key":"2893_CR20","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1148\/radiol.2016160768","volume":"284","author":"WP Kluijfhout","year":"2017","unstructured":"Kluijfhout WP, Pasternak JD, Gosnell JE, Shen WT, Duh QY, Vriens MR, de Keizer B, Hope TA, Glastonbury CM, Pampaloni MH, Suh I (2017) (18)F fluorocholine PET\/MR imaging in patients with primary hyperparathyroidism and inconclusive conventional imaging: a prospective pilot study. Radiology 284(2):460\u2013467","journal-title":"Radiology"},{"issue":"2","key":"2893_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/RLU.0000000000003987","volume":"47","author":"V Liberini","year":"2022","unstructured":"Liberini V, Morand GB, Rupp NJ, Orita E, Deandreis D, Broglie D\u00e4ppen M, Hofbauer M, Maurer A, Husmann L, Mader CE, Gr\u00fcnig H, Alharbi AA, Messerli M, Huellner MW (2022) Histopathological features of parathyroid adenoma and 18F-choline uptake in PET\/MR of primary hyperparathyroidism. Clin.Nucl.Med 47(2):101\u2013107","journal-title":"Clin.Nucl.Med"},{"key":"2893_CR22","doi-asserted-by":"crossref","unstructured":"Araz M, Nak D, Soydal \u00c7, Peker E, Erden \u0130, K\u00fc\u00e7\u00fck N\u00d6 (2021) Detectability of 18F-choline PET\/MR in primary hyperparathyroidism. Eur Arch Otorhinolaryngol 1\u20137","DOI":"10.1007\/s00405-021-07046-3"},{"key":"2893_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2967\/jnmt.112.105122","volume":"40","author":"B Greenspan","year":"2012","unstructured":"Greenspan B, Dillehay G, Intenzo C, Lavely W, O'Doherty M, Palestro C, Scheve W, Stabin M, Sylvestros D, Tulchinsky M (2012) SNM practice guideline for parathyroid scintigraphy 4.0. J Nucl Med Technol 40:111\u2013118","journal-title":"J Nucl Med Technol"},{"key":"2893_CR24","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.surg.2003.06.001","volume":"134","author":"D Carneiro","year":"2003","unstructured":"Carneiro D, Solorzano C, Nader M, Ramirez M, Irvin GL 3rd (2003) Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery 134:973\u2013979","journal-title":"Surgery"},{"issue":"8","key":"2893_CR25","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I","volume":"17","author":"RG Newcombe","year":"1998","unstructured":"Newcombe RG (1998) Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med 17(8):873\u2013890","journal-title":"Stat Med"},{"key":"2893_CR26","doi-asserted-by":"crossref","unstructured":"Hope TA, Graves CE, Calais J, Ehman E, Johnson GB, Thompson D, Aslam M, Duh QY, Gosnell J, Shen W, Roman S, Sosa JA, Kluijfhout W, Seib CS, Villanueva-Meyer J, Pampaloni MH, Suh I (2021) Accuracy of (18)F-fluorocholine PET for the detection of parathyroid adenomas: prospective single center study. J Nucl Med 62","DOI":"10.2967\/jnumed.120.256735"},{"issue":"10","key":"2893_CR27","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1007\/s00259-018-3980-9","volume":"45","author":"M Beheshti","year":"2018","unstructured":"Beheshti M, Hehenwarter L, Paymani Z, Rendl G, Imamovic L, Rettenbacher R, Tsybrovskyy O, Langsteger W, Pirich C (2018) (18)F-fluorocholine PET\/CT in the assessment of primary hyperparathyroidism compared with (99m)Tc-MIBI or (99m)Tc-tetrofosmin SPECT\/CT: a prospective dual-centre study in 100 patients. Eur.J.Nucl.Med.Mol.Imaging 45(10):1762\u20131771","journal-title":"Eur.J.Nucl.Med.Mol.Imaging"},{"key":"2893_CR28","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1001\/jamaoto.2019.0574","volume":"145","author":"LA Boccalatte","year":"2019","unstructured":"Boccalatte LA, Higuera F, G\u00f3mez NL, de la Torre AY, Mazzaro EL, Galich AM, Collaud C, Figari MF (2019) Usefulness of 18F-fluorocholine positron emission tomography-computed tomography in locating lesions in hyperparathyroidism: a systematic review. JAMA Otolaryngol Head Neck Surg 145:743\u2013750","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2893_CR29","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1245\/s10434-016-5694-1","volume":"24","author":"M Jinih","year":"2017","unstructured":"Jinih M, O'Connell E, O'Leary D, Liew A, Redmond H (2017) Focused versus bilateral parathyroid exploration for primary hyperparathyroidism: a systematic review and meta-analysis. Ann Surg Oncol 24:1924\u20131934","journal-title":"Ann Surg Oncol"},{"key":"2893_CR30","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00268-016-3514-1","volume":"40","author":"N Singh Ospina","year":"2016","unstructured":"Singh Ospina N, Rodriguez-Gutierrez R, Maraka S, Espinosa de Ycaza A, Jasim S, Castaneda-Guarderas A, Gionfriddo M, Al Nofal A, Brito J, Erwin P, Richards M, Wermers R, Montori V (2016) Outcomes of parathyroidectomy in patients with primary hyperparathyroidism: a systematic review and meta-analysis. World J Surg 40:2359\u20132377","journal-title":"World J Surg"},{"key":"2893_CR31","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","volume":"151","author":"S Wilhelm","year":"2016","unstructured":"Wilhelm S, Wang T, Ruan D, Lee J, Asa S, Duh Q, Doherty G, Herrera M, Pasieka J, Perrier N, Silverberg S, Sol\u00f3rzano C, Sturgeon C, Tublin M, Udelsman R, Carty S (2016) The American Association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg 151:959\u2013968","journal-title":"JAMA Surg"},{"issue":"6","key":"2893_CR32","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s00268-011-1365-3","volume":"36","author":"A Mahajan","year":"2012","unstructured":"Mahajan A, Starker LF, Ghita M, Udelsman R, Brink JA, Carling T (2012) Parathyroid four-dimensional computed tomography: evaluation of radiation dose exposure during preoperative localization of parathyroid tumors in primary hyperparathyroidism. World J Surg 36(6):1335\u20131339","journal-title":"World J Surg"},{"issue":"5","key":"2893_CR33","doi-asserted-by":"publisher","first-page":"W579","DOI":"10.2214\/AJR.14.13278","volume":"204","author":"JK Hoang","year":"2015","unstructured":"Hoang JK, Reiman RE, Nguyen GB, Januzis N, Chin BB, Lowry C, Yoshizumi TT (2015) Lifetime attributable risk of cancer from radiation exposure during parathyroid imaging: comparison of 4D CT and parathyroid scintigraphy. AJR Am J Roentgenol 204(5):W579\u2013W585","journal-title":"AJR Am J Roentgenol"},{"key":"2893_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.surg.2021.03.075","volume":"171","author":"A Yap","year":"2022","unstructured":"Yap A, Hope TA, Graves CE, Kluijfhout W, Shen WT, Gosnell JE, Sosa JA, Roman SA, Duh QY, Suh I (2022) A cost-utility analysis of 18F-fluorocholine-positron emission tomography imaging for localizing primary hyperparathyroidism in the United States. Surgery 171:55\u201362","journal-title":"Surgery"},{"issue":"1","key":"2893_CR35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1088\/1361-6498\/aaa86f","volume":"38","author":"S Rep","year":"2018","unstructured":"Rep S, Hocevar M, Vaupotic J, Zdesar U, Zaletel K, Lezaic L (2018) (18)F-choline PET\/CT for parathyroid scintigraphy: significantly lower radiation exposure of patients in comparison to conventional nuclear medicine imaging approaches. J.Radiol.Prot 38(1):343\u2013356","journal-title":"J.Radiol.Prot"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-023-02893-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-023-02893-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-023-02893-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T19:05:37Z","timestamp":1705604737000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-023-02893-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,20]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2893"],"URL":"https:\/\/doi.org\/10.1007\/s00423-023-02893-6","relation":{},"ISSN":["1435-2451"],"issn-type":[{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,20]]},"assertion":[{"value":"17 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Patients signed informed consent regarding publishing their data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"155"}}